Tretinoin is the pharmaceutical form of retinoic acid. One of several retinoids, it is the carboxylic acid form of vitamin A and is also known as all-trans retinoic acid (ATRA). It is a first generation topical retinoid commonly used topically to treat acne vulgaris. It is also used orally to treat acute promyelocytic leukemia (APL). Its isomer, isotretinoin, is also an acne drug. It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system.
Market Analysis and Insights: Global Tretinoin Market
The global Tretinoin market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Tretinoin Scope and Market Size
The global Tretinoin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tretinoin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
0.1% Tretinoin
0.02% Tretinoin
0.025% Tretinoin
0.05% Tretinoin
Segment by Application
Skin Disease
Leukemia
The Tretinoin market is analysed and market size information is provided by regions (countries). Segment by Application, the Tretinoin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
BASF
LGM Pharma
GF Health
Gyma Laboratories
Genemed Synthesis
IMCoPharma
Chongqing Huabang
Olon
Sun Pharma.
Market Segment by Manufacturers, this report covers
BASF, LGM Pharma, GF Health, Gyma Laboratories, Genemed Synthesis, IMCoPharma, Chongqing Huabang, Olon S.p.A., Sun Pharma.Market Analysis and Insights: Global Tretinoin Market
The global Tretinoin market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Tretinoin Scope and Market Size
The global Tretinoin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tretinoin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
0.1% Tretinoin
0.02% Tretinoin
0.025% Tretinoin
0.05% Tretinoin
Segment by Application
Skin Disease
Leukemia
The Tretinoin market is analysed and market size information is provided by regions (countries). Segment by Application, the Tretinoin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
BASF
LGM Pharma
GF Health
Gyma Laboratories
Genemed Synthesis
IMCoPharma
Chongqing Huabang
Olon
Sun Pharma.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.